European Commission grants approval for cladribine
Posted: Tue Aug 29, 2017 4:04 am
The European Commission has approved Mavenclad, more commonly known as cladribine, for the treatment of highly active relapsing remitting multiple sclerosis (RRMS) patients across Europe...Read more - http://www.ms-uk.org/european-commissio ... cladribine